Download Docs
Export

GLPSYNERGI

50219296 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 16, 2026
Serial No. 50219296
Class Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals, pharmaceutical preparations, dietetic preparations, dietary supplements, food supplements and nutraceuticals; Chemical additives for use in the manufacture of pharmaceuticals, pharmaceutical preparations, dietetic preparations, dietary supplements, food supplements and nutraceuticals; Biochemicals for use in the manufacture of preparations intended to enhance patient tolerability of pharmaceutical treatments, in particular by reducing gastrointestinal side effects such as nausea, vomiting, diarrhea and indigestion, while preserving therapeutic efficacy; Chemical preparations for use in the manufacture of preparations intended to enhance patient tolerability of pharmaceutical treatments, in particular by reducing gastrointestinal side effects such as nausea, vomiting, diarrhea and indigestion, while preserving therapeutic efficacy; Chemical additives for use in pharmaceutical, nutraceutical and dietary formulations designed to improve digestive comfort and gastrointestinal tolerance; Chemicals, namely, chemical substances for use as food ingredients and as functional ingredients in dietary supplements and nutraceutical compositions aimed at supporting digestive function and tolerance; Plant extracts for use in the manufacture of pharmaceuticals, pharmaceutical preparations, dietary supplements, nutritional supplements, food supplements, nutraceuticals and foods, in particular for improving gastrointestinal tolerability; Chemicals, namely, bioactive compounds of natural or synthetic origin intended for use in formulations designed to mitigate digestive discomfort associated with pharmacological treatments, including GLP-1 based therapies; Chemicals, namely, biochemical compounds and functional ingredients for use in formulations aimed at supporting gastrointestinal comfort and tolerance; Chemicals, namely, chemical ingredients derived from plant, microbial or synthetic sources for use in the industrial manufacture of pharmaceutical products and nutraceutical compositions intended to reduce treatment-related digestive side effects; Chemicals, namely, raw chemical materials and bioactive compounds for the formulation of food supplements, dietary supplements and nutraceuticals supporting digestive tolerance; Plant extracts for use in the manufacture of dietary supplements; Chemical preparations for preserving foodstuffs; 001; 005; 006; 010; 026; 046; 005; 006; 018; 044; 046; 051; 052
GLPSYNERGI
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 1 day, 11 hours ago
Filing Date # Docket Text
to view the full docket.